Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
91,839,202
-
Share change
-
+1,793,555
-
Total reported value
-
$6,693,183,477
-
Put/Call ratio
-
42%
-
Price per share
-
$72.91
-
Number of holders
-
269
-
Value change
-
+$108,404,837
-
Number of buys
-
125
-
Number of sells
-
140
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2018
As of 31 Dec 2018,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,839,202 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., BAILLIE GIFFORD & CO, DODGE & COX, PRICE T ROWE ASSOCIATES INC /MD/, MAVERICK CAPITAL LTD, STATE STREET CORP, and BB BIOTECH AG.
This page lists
271
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.